Literature DB >> 25579560

Radiation recall phenomenon presenting as myositis triggered by carboplatin plus paclitaxel and related literature review.

Chi Hoon Maeng, Jun Sang Park, Seung Ah Lee, Dong Hwan Kim, Dong Hwan Yun, Seung-Don Yoo, Hee-Sang Kim, Jinmann Chon1.   

Abstract

While most case reports to date are radiation recall dermatitis, radiation recall myositis, which is a distinct form of radiation recall phenomenon caused by carboplatin plus paclitaxel, has not been reported. We treated a 57-year-old female patient who suffered from recurrent cervical cancer. When the patient developed a new left sacral metastasis, salvage radiotherapy (total dose 60 Gy) was administered. Four weeks later, chemotherapy using carboplatin plus paclitaxel was initiated. Four months after chemotherapy, the patient complained of severe pain in her left buttock. On magnetic resonance imaging (MRI), edematous changes and increased signal densities of left gluteus maximus and medius muscles were noted suggesting myositis. The border of the high signal intensity territory of the muscles was sharp and clearly corresponded with the recent irradiation field. We concluded that the patient had radiation recall myositis triggered by paclitaxel-carboplatin. Symptoms were controlled by analgesics, and there was no recurrence.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25579560     DOI: 10.4103/0973-1482.146090

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  2 in total

1.  Myositis following spine radiosurgery for metastatic disease: a case series.

Authors:  Dennis T Lockney; Angela Y Jia; Eric Lis; Natalie A Lockney; Chengbao Liu; Benjamin Hopkins; Daniel S Higginson; Yoshiya Yamada; Ilya Laufer; Mark Bilsky; Adam M Schmitt
Journal:  J Neurosurg Spine       Date:  2018-01-26

2.  Sociodemographic, clinical profile, and treatment characteristics of oncology patients developing radiation recall phenomenon: Two tertiary care center's experience of an eternal unpredictable phenomenon of cancer treatment.

Authors:  Abhishek Purkayastha; Neelam Sharma; Sachin Taneja; Virender Suhag; Nishant Lohia
Journal:  Tzu Chi Med J       Date:  2021-12-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.